Skip to main content

Table 2 Price trends for first-line, three-in-one FDCs and their component ARVs

From: Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

  Median (25th, 75th percentile) Regimen Prices* in USD
  2002 2003 2004 2005 2006 2007 2008
3TC, NVP, d4T40        
Generic NVP+3TC+d4T40 490
(486, 496)
418
(245, 489)
212
(184, 249)
209
(183, 255)
169
(150, 172)
114
(108, 130)
107
(97, 149)
Brand NVP+3TC+d4T40    640
(640, 648)
619
(619, 707)
618
(597, 746)
637
(370, 954)
897
(601, 1,219)
Generic FDC   165* 180
(143, 193)
180
(163, 214)
112
(112, 129)
83
(83, 102)
104
(80, 151)
ABC, 3TC, ZDV        
Generic ABC+3TC+ZDV    1,083
(510, 1591)
1,101
(1,039, 1,212)
794
(744, 813)
568
(525, 626)
475
(436, 587)
Brand ABC+3TC+ZDV   1,669* 1,329
(1,329, 1,363)
1,286
(1,285, 1,387)
1,282
(978, 1,354)
984
(938, 991)
702
(681, 1,064)
Brand FDC   1,652* 1,483* 1,366
(1,366, 1,489)
1,363* 883
(883, 989)
 
EFV, FTC, TDF        
Generic EFV + FTC/TDF       516
(417, 536)
464
(441, 487)
Brand EFV + FTC/TDF     781* 678
(636, 769)
593
(579, 624)
619
(573, 834)
Generic FDC        485*
Brand FDC       712* 613*
  1. *25th and 75th percentiles not calculated because n < 5 purchases